Skip to main content Skip to secondary navigation
Main content start

2022 Biotechnology Symposium

Event Details:

Tuesday, April 5, 2022
1:00pm - 5:00pm PDT

This event is open to:

Alumni/Friends
Faculty/Staff
Students

Please register in advance at: https://bit.ly/3MCNq6w

Our annual Stanford Biotechnology Symposium will be held in person, on Tuesday, April 5, 2022, 1 pm to 4 pm (PST)

Featuring:

  • Keynotes by Rachel Haurwitz & Joe DeSimone
  • Panel Discussion with Biotechnology Program Alumni
  • Poster Sessions by NIH Stanford Biotechnology Program Trainees
Rachel Haurwitz is a co-founder of Caribou Biosciences and has been its President and Chief Executive Officer and a director since the company’s inception in 2011. Rachel is an inventor on patents and patent applications covering multiple CRISPR-based technologies and has co-authored several scientific papers in high-impact journals characterizing CRISPR-Cas systems. In 2014, she was named by Forbes Magazine to the “30 Under 30” list in Science and Healthcare, and in 2016, Fortune Magazine named her to the “40 Under 40” list of the most influential young people in business. In 2018, the Association for Women in Science recognized Rachel with the annual Next Generation Award. She serves on the board of directors of Seer, Inc. and the Biotechnology Innovation Organization (BIO).
 
Joseph M. DeSimone is the Sanjiv Sam Gambhir Professor of Translational Medicine and Chemical Engineering at Stanford University. He holds appointments in the Departments of Radiology and Chemical Engineering with courtesy appointments in the Department of Chemistry and in Stanford’s Graduate School of Business. The DeSimone laboratory's research efforts are focused on developing innovative, interdisciplinary solutions to complex problems centered around advanced polymer 3D fabrication methods. In Chemical Engineering and Materials Science, the lab is pursuing new capabilities in digital 3D printing, as well as the synthesis of new polymers for use in advanced additive technologies. In Translational Medicine, research is focused on exploiting 3D digital fabrication tools to engineer new vaccine platforms, enhanced drug delivery approaches, and improved medical devices for numerous conditions, with a current major focus in pediatrics. Complementing these research areas, the DeSimone group has a third focus in Entrepreneurship, Digital Transformation, and Manufacturing.
 
Registration is required.  

 

Schedule

Tuesday, April 5, 2022

  • -

    Welcome from the BTP Program Directors

  • -

    Keynote 1: Rachel Haurwitz, CEO Caribou Biosciences

  • -

    Panel Discussion

  • -

    Lightning Research Talks I

  • -

    Coffee Break

  • -

    Keynote II: Joseph DeSimone, Stanford University, former CEO Carbon

  • -

    Lightning Research Talks II

  • -

    Closing Remarks

  • -

    Poster Session (with drinks, snacks, & prize drawing)

  • -

    Guided Tour of the Engineering Quad (Optional)

Explore More Events

No events at this time. Please check back later.